Inventor
SANG YINGXIA
CN9 patents
⚠️ This page may combine multiple inventors who share the name “SANG YINGXIA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GLAXOSMITHKLINE IP DEV LTD
7 patentsUS9815841B2Nov 14, 2017
Compounds
GLAXOSMITHKLINE IP DEV LTD2 citations69
US10975081B2Apr 13, 2021
Substituted fused pyrazole compounds and their use as LRRK2 inhibitors
GLAXOSMITHKLINE IP DEV LTD1 citations61
US10618901B2Apr 14, 2020
LRRK2 inhibitors for the treatment of Parkinson's disease
GLAXOSMITHKLINE IP DEV LTD1 citations60
US11034696B2Jun 15, 2021
Compounds for inhibiting LRRK2 kinase activity
GLAXOSMITHKLINE IP DEV LTD1 citations59
US9051325B2Jun 9, 2015
Bicyclic [5,6] imidazo pyrimodone compounds for use in the treatment of diseases or conditions mediated by Lp-PLA2
GLAXOSMITHKLINE IP DEV LTD0 citations51
US9708330B2Jul 18, 2017
2,3-dihydroimidazol[1,2-C]pyrimidin-5(1-H)-one based ipoprotein-associated phospholipase A2 (Lp-PLA2) inhibitors
GLAXOSMITHKLINE IP DEV LTD0 citations40
US10858367B2Dec 8, 2020
Compounds
GLAXOSMITHKLINE IP DEV LTD0 citations39